Effects of ginsenoside CK pretreatment on oxidative stress and inflammation in rats with cerebral ischemia/reperfusion injury

References

• Malkki H. Cerebrovascular disorders: cerebral microbleeds linked to increased risk of cognitive decline. Nat Rev Neurol. 2016;12:432–433.
   PubMedGoogle Scholar
• He Z, Tang Y, Qin C. Increased circulating leukocyte-derived microparticles in ischemic cerebrovascular disease. Thromb Res. 2017;154:19–25.
   PubMed Web of Science ®Google Scholar
• Dong Y, Lu K, Gao W. Application frequency and therapeutic effect of Astragalus in treating ischemic cerebrovascular disease. Pak J Pharm Sci. 2016;29:2213–2216.
   PubMed Web of Science ®Google Scholar
• Winquist RJ, Kerr S. Cerebral ischemia-reperfusion injury and adhesion. Neurology. 1997;49:S23–S26.
   PubMed Web of Science ®Google Scholar
• Chen XM, Chen HS, Xu MJ, et al. Targeting reactive nitrogen species: A promising therapeutic strategy for cerebral ischemia-reperfusion injury. Acta Pharmacol Sin. 2013;34:67–77.
   PubMed Web of Science ®Google Scholar
• Wong CH, Crack PJ. Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Curr Med Chem. 2008;15:1–14.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhao S. Progress in understanding of ginsenoside biosynthesis. Plant Biol (Stuttg). 2008;10:415–421.
   PubMed Web of Science ®Google Scholar
• Akao T, Kida H, Kanaoka M, et al. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol. 1998;50:1155–1160.
   PubMed Web of Science ®Google Scholar
• Bao C, Wang Y, Min H, et al. Combination of ginsenoside Rg1 and bone marrow mesenchymal stem cell transplantation in the treatment of cerebral ischemia reperfusion injury in rats. Cell Physiol Biochem. 2015;37:901–910.
   PubMed Web of Science ®Google Scholar
• Lu T, Jiang Y, Zhou Z, et al. Intranasal ginsenoside Rb1 targets the brain and ameliorates cerebral ischemia/reperfusion injury in rats. Biol Pharm Bull. 2011;34:1319–1324.
   PubMed Web of Science ®Google Scholar
• Xie Z, Shi M, Zhang C, et al. Ginsenoside Rd protects against cerebral ischemia-reperfusion injury via decreasing the expression of the NMDA receptor 2B subunit and its phosphorylated product. Neurochem Res. 2016;41:2149–2159.
   PubMed Web of Science ®Google Scholar
• Chen LM, Zhou XM, Cao YL, et al. Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats. J Asian Nat Prod Res. 2008;10:439–445.
   PubMed Web of Science ®Google Scholar
• Gao XJ, Xie GN, Liu L, et al. Sesamol attenuates oxidative stress, apoptosis and inflammation in focal cerebral ischemia/reperfusion injury. Exp Ther Med. 2017;14:841–847.
   PubMed Web of Science ®Google Scholar
• Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17:472–476.
   PubMed Web of Science ®Google Scholar
• Cetin C, Erdogan AM, Dincel GC, et al. Effects of sulphasalazine in cerebral ischemia reperfusion injury in rat. Arch Med Res. 2017;48:247–256.
   PubMed Web of Science ®Google Scholar
• Koizumi JI, Yoshida Y, Nakazawa T, et al. Experimental studies of ischemic brain edema: A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke. 1986;8:1–8.
   Google Scholar
• Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84–91.
   PubMed Web of Science ®Google Scholar
• Hosoo H, Marushima A, Nagasaki Y, et al. Neurovascular unit protection from cerebral ischemia-reperfusion injury by radical-containing nanoparticles in mice. Stroke. 2017;48:2238–2247.
   PubMed Web of Science ®Google Scholar
• Marushima A, Suzuki K, Nagasaki Y, et al. Newly synthesized radical-containing nanoparticles enhance neuroprotection after cerebral ischemia-reperfusion injury. Neurosurgery. 2011;68:1418–1426.
   PubMed Web of Science ®Google Scholar
• Fang Y, Liu X, Zhao L, et al. RhGLP-1 (7-36) protects diabetic rats against cerebral ischemia-reperfusion injury via up-regulating expression of Nrf2/HO-1 and increasing the activities of SOD. Korean J Physiol Pharmacol. 2017;21:475–485.
   PubMed Web of Science ®Google Scholar
• Schmitt B, Vicenzi M, Garrel C, et al. Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover study. Redox Biol. 2015;6:198–205.
   PubMed Web of Science ®Google Scholar
• Deepika ML, Nalini S, Maruthi G, et al. Analysis of oxidative stress status through MN test and serum MDA levels in PCOS women. Pak J Biol Sci. 2014;17:574–577.
   PubMedGoogle Scholar
• Li W, Tan C, Liu Y, et al. Resveratrol ameliorates oxidative stress and inhibits aquaporin 4 expression following rat cerebral ischemia-reperfusion injury. Mol Med Rep. 2015;12:7756–7762.
   PubMed Web of Science ®Google Scholar
• Shao X, Li N, Zhan J, et al. Protective effect of compound K on diabetic rats. Nat Prod Commun. 2015;10:243–245.
   PubMed Web of Science ®Google Scholar
• Wang X, An F, Wang S, et al. Orientin attenuates cerebral ischemia/reperfusion injury in rat model through the AQP-4 and TLR4/NF-κB/TNF-α signaling pathway. J Stroke Cerebrovasc Dis. 2017;26:2199–2214.
   PubMed Web of Science ®Google Scholar
• Zhang DD, Zou MJ, Zhang YT, et al. A novel IL-1RA-PEP fusion protein with enhanced brain penetration ameliorates cerebral ischemia-reperfusion injury by inhibition of oxidative stress and neuroinflammation. Exp Neurol. 2017;297:1–13.
   PubMed Web of Science ®Google Scholar
• Joh EH, Lee I, Jung IH, et al. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochem Pharmacol. 2011;82:278–286.
   PubMed Web of Science ®Google Scholar
• Yang S, Xu L, Yang T, et al. High-mobility group box-1 and its role in angiogenesis. J Leukoc Biol. 2014;95:563–574.
   PubMed Web of Science ®Google Scholar
• Jiang WL, Xu Y, Zhang SP, et al. Tricin 7-glucoside protects against experimental cerebral ischemia by reduction of NF-κB and HMGB1 expression. Eur J Pharm Sci. 2012;45:50–57.
   PubMed Web of Science ®Google Scholar
• Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000;192:565–570.
   PubMed Web of Science ®Google Scholar
• Tsung A, Klune JR, Zhang X, et al. HMGB1 release induced by liver ischemia involves toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med. 2007;204:2913–2923.
   PubMed Web of Science ®Google Scholar
• Tao X, Sun X, Yin L, et al. Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition. Free Radic Biol Med. 2015;84:103–115.
   PubMed Web of Science ®Google Scholar
• Wang N, Guo QL, Ye Z, et al. Preconditioning of intravenous parecoxib attenuates focal cerebral ischemia/reperfusion injury in rats. Chin Med J (Engl). 2011;124:2004–2008.
   PubMed Web of Science ®Google Scholar